Antony Hsu is responsible for Caliway’s business development activities, including fundraising, commercialization and corporate development, and launch planning.
Vivian LingChief Executive Officer/Chief R&D Officer
Vivian Ling is responsible for Caliway’s Research & Development, including drug discovery research, non-clinical and clinical development, and regulatory affairs.
Dr. Kao-Jung ChangDirector
Dr. Chang is mainly responsible for the clinical application of new drugs.